Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes
Authors:
- Dream On (Diabetes Reduction Assessment With RamiprilDRDream On (Diabetes Reduction Assessment With Ramipril
- Rosiglitazone Medication Ongoing Follow-up) InvestigatorsRIRosiglitazone Medication Ongoing Follow-up) Investigators
- 30 November 2010
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 54 (3) , 487-495
Abstract
The Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) trial reported that 3 years of therapy with rosiglitazone reduced the primary outcome of diabetes or death by 60%. Here we investigated whether an effect on diabetes prevention persists more than 1.5 years after therapy has been discontinued.Keywords
This publication has 16 references indexed in Scilit:
- Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention StudyThe Lancet, 2006
- Effect of Ramipril on the Incidence of DiabetesNew England Journal of Medicine, 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia, 2006
- Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention ProgramDiabetes, 2005
- Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT malesDiabetes Research and Clinical Practice, 2005
- Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trialDiabetologia, 2004
- Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic WomenDiabetes, 2002
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes StudyDiabetes Care, 1997